Zhang, Na

Mannan-Modified Solid Lipid Nanoparticles for Targeted Gene Delivery to Alveolar Macrophages

Yu, W., Liu, C., Liu, Y., Zhang, N., & Xu, W. (2010) · Pharmaceutical Research

RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery

Cited by 137

Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis

Zhang, N., Jiang, J., Tang, S., & Sun, G. (2020) · International Immunopharmacology

Inflammatory Biomarkers in Disease PrognosisCancer Immunotherapy and Biomarkers

Cited by 109

Tumor Specific Delivery and Therapy by Double-Targeted Nanostructured Lipid Carriers with Anti-VEGFR-2 Antibody

Liu, D., Liu, F., Liu, Z., Wang, L., & Zhang, N. (2011) · Molecular Pharmaceutics

Nanoparticle-Based Drug DeliveryAngiogenesis and VEGF in Cancer

Cited by 108

Delivery Strategy to Enhance the Therapeutic Efficacy of Liver Fibrosis via Nanoparticle Drug Delivery Systems

Liu, J., Liu, J., Mu, W., Ma, Q., Zhai, X., Jin, B., Liu, Y., & Zhang, N. (2024) · ACS Nano

Nanoparticle-Based Drug DeliveryLiver physiology and pathology

Cited by 74

The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vessels

Iivanainen, E., Lauttia, S., Zhang, N., Tvorogov, D., Kulmala, J., Grenman, R., Salven, P., & Elenius, K. (2009) · Microvascular Research

Angiogenesis and VEGF in CancerBarrier Structure and Function Studies

Cited by 34